Have a medical question?
- Learn about your treatment options
- Ask questions about your diagnosis
- Get doctor recommendations
Written By: Karen Ritter, RN BSN
Mesothelioma Multimodal Therapy
Mesothelioma multimodal therapy is a combination approach to the treatment of mesothelioma. Doctors use multiple therapies to improve life expectancy for mesothelioma patients. Surgery, chemotherapy and radiation are often featured in mesothelioma multimodal therapy.
Dr. Hassan Khalil
Mesothelioma Thoracic Surgeon
Dr. Khalil is a mesothelioma thoracic surgeon at Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Khalil has been a medical reviewer for Mesothelioma Guide since 2021. He prioritizes ensuring the accuracy, relevancy and completeness of all medical information published on this website. Learn more about Dr. Hassan Khalil
AI Summary of Mesothelioma Multimodal Therapy
Mesothelioma multimodal therapy is a comprehensive approach that combines different treatment methods to improve outcomes for patients diagnosed with this challenging cancer. Since mesothelioma often resists single therapies, combining treatments such as surgery, chemotherapy, radiation, and emerging options like immunotherapy aims to attack the disease from multiple angles, increasing the chance of controlling or reducing tumor growth. This approach is designed to help patients live longer and with a better quality of life by reducing the risk of tumor resistance and spread.
To access multimodal therapy, the first step is obtaining an accurate diagnosis from experienced medical professionals. Once diagnosed, patients can work with specialized cancer care teams and patient advocates to identify the best treatment centers that offer multi-treatment options. These centers often develop personalized treatment plans based on the patient’s overall health, tumor location, and disease stage, which may include surgery followed by chemotherapy and radiation, or vice versa. Some emerging therapies, like immunotherapy, tumor treating fields, and intraoperative treatments, are increasingly integrated into multimodal plans as research advances.
The rationale behind multimodal therapy is that combining multiple treatment modalities can produce a synergistic effect, meaning each therapy enhances the effectiveness of the others. For example, immunotherapy can make the immune system stronger in fighting cancer, while chemotherapy weakens tumors and makes them more vulnerable. Radiation helps destroy cancer cells’ DNA, prompting immune responses. When these treatments are used together, they can work more effectively than alone, slowing or stopping cancer growth for longer periods. While some components like surgery and radiation remain experimental or are under clinical trial evaluation, their combination with FDA-approved options like certain chemotherapies and immunotherapies is showing promising results.
Many top cancer treatment centers in the country now offer multimodal therapy tailored to each patient’s needs. Such centers employ advanced surgical techniques, like pleurectomy with decortication or extrapleural pneumonectomy, often combined with treatments like hyperthermic intraoperative chemotherapy. They may also incorporate cutting-edge therapies such as gene therapy, virotherapy, or photodynamic treatments, which are still under investigation but hold potential for the future. Navigating these complex options can be overwhelming, but dedicated teams at specialized centers work carefully to create the most effective treatment plans. Patients and their families should seek out experienced providers and advocate for access to these advanced, combined therapies to optimize their chances of managing mesothelioma effectively.
